Send us a text

Can lifestyle choices truly prevent more than 50% of dementia cases? Join Dr. Douglas Beck and Dr. Dung Trinh as we explore this thought-provoking question and uncover groundbreaking insights. Our discussion dives into the 2024 Lancet study, highlighting 14 modifiable risk factors for dementia and the potential to prevent or delay nearly half of all cases. You'll learn about the crucial role primary care plays in managing Alzheimer's amidst a shortage of neurologists and the importance of addressing lifestyle factors like sleep and obesity. We also weigh the benefits and challenges of FDA-approved monoclonal antibodies, exploring their promise and limitations.

In our in-depth conversation, we explore the evolving landscape of Alzheimer's detection and treatment. Hear about the promising potential of biomarkers like P-tau-217 and the role of genetic factors like APOE4. We discuss shifting treatment strategies, moving beyond amyloid-targeted therapies to consider tau proteins and the immune system's involvement. The conversation also shines a light on the flaws in our healthcare system's focus on treatment over prevention, examining the impact of lifestyle industries and Medicare Advantage plans on preventive health measures. Join us for this enlightening discussion that promises to challenge your understanding of Alzheimer's care and prevention.

Connect with the Hearing Matters Podcast Team

Email: [email protected]

Instagram: @hearing_matters_podcast

Twitter: @hearing_mattas

Facebook: Hearing Matters Podcast